Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.

Luca Ielasi Bernardo StefaniniFabio ContiMatteo TonniniRaffaella TortoraGiulia MaginiRodolfo SaccoTiziana PressianiFranco Trevisani Francesco Giuseppe Foschi Piscaglia Fabio Alessandro Granito Francesco Tovoli

Published in: Current oncology (Toronto, Ont.) (2024)

Intermediate-stage subclassification systems maintain their predictive value also in the setting of systemic therapy. The Bolondi and Wang criteria showed the highest accuracy. AFP > 400 ng/mL enhances the performance of these systems.

Keyphrases

machine learning
primary care
drug induced